Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2011-11-08 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIUZ-EN-SALLAZ (74250), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE VIUZ : revenue, balance sheet and financial ratios
PHARMACIE DE VIUZ is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIUZ-EN-SALLAZ (74250),
this company of category PME
shows in 2024 a net income positive of 410 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE VIUZ (SIREN 537773889)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
409 579 €
348 106 €
365 371 €
204 676 €
176 294 €
160 788 €
118 663 €
229 246 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE VIUZ generates positive net income of 410 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 229 k€ -> 410 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
409 579 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 174%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
174.479%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.82%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
292.015
292.337
230.118
179.674
755.562
482.98
257.13
174.479
Financial autonomy
22.728
22.549
26.881
31.355
10.275
14.681
22.892
29.82
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
174.482024
2021
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DE VIUZ (174.48) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.82%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DE VIUZ (29.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 100.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
100.033
Liquidity indicators evolution PHARMACIE DE VIUZ
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
150.131
148.143
143.916
134.396
152.764
128.516
39.664
100.033
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
100.032024
2021
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE DE VIUZ (100.03) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DE VIUZ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE VIUZ is estimated at
5 718 025 €
(range 3 981 942€ - 8 554 493€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3981k€5718k€8554k€
5 718 025 €Range: 3 981 942€ - 8 554 493€
NAF 5 année 2024
Valuation method used
Net Income Multiple
409 579 €
×
14.0x
=5 718 026 €
Range: 3 981 943€ - 8 554 494€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE VIUZ with other companies in the same sector:
Frequently asked questions about PHARMACIE DE VIUZ
What is the revenue of PHARMACIE DE VIUZ ?
The revenue of PHARMACIE DE VIUZ is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE VIUZ profitable?
Yes, PHARMACIE DE VIUZ generated a net profit of 410 k€ in 2024.
Where is the headquarters of PHARMACIE DE VIUZ ?
The headquarters of PHARMACIE DE VIUZ is located in VIUZ-EN-SALLAZ (74250), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DE VIUZ ?
The tax return of PHARMACIE DE VIUZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE VIUZ operate?
PHARMACIE DE VIUZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart